BamSEC and AlphaSense Join Forces
Learn More

Amesite Inc. – Indentures

NASDAQ: AMST    
Share price (6/26/26): $1.09    
Market cap (6/26/26): $6.380 million

Indentures Filter

EX-4.4
from 8-K 15 pages Placement Agent Common Stock Purchase Warrant Amesite Inc
12/34/56
EX-4.3
from 8-K 14 pages Series A-2 Common Stock Purchase Warrant Amesite Inc
12/34/56
EX-4.2
from 8-K 14 pages Series A-1 Common Stock Purchase Warrant Amesite Inc
12/34/56
EX-4.1
from 8-K 16 pages Pre-Funded Common Stock Purchase Warrant Amesite Inc
12/34/56
EX-4.10
from S-1 17 pages Common Stock Purchase Warrant Amesite Inc
12/34/56
EX-4.9
from S-1 16 pages Pre-Funded Common Stock Purchase Warrant Amesite Inc
12/34/56
EX-4.8
from S-1 20 pages Common Stock Purchase Warrant Amesite Inc
12/34/56
EX-4.3
from S-8 1 page Second Amendment to Amesite Inc. 2018 Equity Incentive Plan
12/34/56
EX-4.3
from S-3/A 70 pages Recitals of the Company
12/34/56
EX-4.2
from S-3/A 64 pages Recitals of the Company
12/34/56
EX-4.3
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 8-K 16 pages Placement Agent Common Stock Purchase Warrant Amesite Inc
12/34/56
EX-4.1
from 8-K 14 pages Common Stock Purchase Warrant Amesite Inc
12/34/56
EX-4.1
from 8-K 11 pages Underwriter’s Warrant
12/34/56
EX-4.3
from S-3 37 pages Aditx Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of , 20 Subordinated Debt Securities
12/34/56
EX-4.2
from S-3 37 pages Amesite Inc. Issuer and [Trustee], Trustee Indenture Dated as of , 20 Senior Debt Securities
12/34/56
EX-4.1
from S-8 17 pages Amesite Inc. 2018 Equity Incentive Plan Adopted by Board: April 26, 2018 Approved by Stockholders: April 26, 2018 Termination Date: April 26, 2028
12/34/56
EX-4.2
from S-1/A 11 pages Form of Underwriter’s Warrant
12/34/56
EX-4.1
from S-1/A 2 pages Specimen Stock Certificate Evidencing the Shares of Common Stock
12/34/56